Genetic Evidence for the Benefits and Risks of Glucose-Lowering Drugs on Cardiovascular-Kidney-Metabolic Syndrome: A Drug-Target Mendelian Randomization Study
International Journal of Medical Sciences · 11.05.2026 · 23 (7) · 2197-2208
DOI: 10.7150/ijms.133077 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Medical Sciences, erschienen am 11.05.2026. Verfasst von Jian Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Cardio-Renal Syndrome. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.
- Department of Nephrology, Capital Medical University China-Japan Friendship School of Clinical Medicine, Beijing, China.
- Department of Nephrology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
- School of Basic Medical Sciences, Capital Medical University, Beijing, China.
- School of Public Health, Capital Medical University, Beijing, China.
- School of Healthcare Management, Tsinghua Medicine, Tsinghua University, Beijing, China.
Zitieren
APA
Lu, J., Sun, S., Shang, X., Jiang, S., Deng, Z., Wang, S., Wei, C., Hu, J., & Li, W. (2026). Genetic Evidence for the Benefits and Risks of Glucose-Lowering Drugs on Cardiovascular-Kidney-Metabolic Syndrome: A Drug-Target Mendelian Randomization Study. International Journal of Medical Sciences, 23(7), 2197-2208. https://doi.org/10.7150/ijms.133077
Vancouver
Lu J, Sun S, Shang X, Jiang S, Deng Z, Wang S, et al. Genetic Evidence for the Benefits and Risks of Glucose-Lowering Drugs on Cardiovascular-Kidney-Metabolic Syndrome: A Drug-Target Mendelian Randomization Study. International Journal of Medical Sciences. 2026;23(7):2197-2208. doi:10.7150/ijms.133077
BibTeX
@article{Lu2026,
author = {Lu, Jian and Sun, Shuaigang and Shang, Xinru and Jiang, Shimin and Deng, Zekai and Wang, Shunwei and Wei, Chenping and Hu, Jiaqi and Li, Wenge},
title = {Genetic Evidence for the Benefits and Risks of Glucose-Lowering Drugs on Cardiovascular-Kidney-Metabolic Syndrome: A Drug-Target Mendelian Randomization Study},
journal = {International Journal of Medical Sciences},
year = {2026},
volume = {23},
number = {7},
pages = {2197--2208},
doi = {10.7150/ijms.133077}
}
EUVIMED